Browsing by Author "Felip Font, Enriqueta"
Now showing items 1-20 of 60
-
A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study
Isla, Dolores; Felip Font, Enriqueta; Garrido, Pilar; Majem Tarruella, Margarita; Trigo, José Manuel; de Castro Carpeno, Javier; Remon, Jordi; Insa, Amelia (Springer, 2023-01) -
A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate Midazolam in Patients With ALK-Positive or ROS1-Positive Solid Tumors
Hanley, Michael J; D’Arcangelo, Manolo; Felip Font, Enriqueta; Garrido, Pilar; Zhu, Jiaxi; Ye, Meng (Wiley, 2023-05) -
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology
Lazar, Vladimir; Zhang, Baolin; Magidi, Shai; Raymond, Eric; Ducreux, M.; Felip Font, Enriqueta; Tabernero Caturla, Josep; Le Tourneau, Christophe (SAGE Publications, 2023) -
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer
Callejo Perez, Ana; Bar, Jair; Berchem, Guy; Bazhenova, Lyudmila; Saintigny, Pierre; Felip Font, Enriqueta; Solomon, Benjamin (Wiley, 2022-07) -
Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience
Oleas, Diana; Bolufer Cardona, Monica; Agraz Pamplona, Irene; Felip Font, Enriqueta; Gabaldon Dominguez, Alejandra; Bury, Roxana; Espinel Garuz, María Eugenia; Serón Micas, Daniel; García Carro, Clara; Soler Romeo, Maria Jose; Muñoz Couselo, Eva (Oxford University Press, 2021-05) -
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial
Goss, Glenwood D.; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Goker, Erdem; Felip Font, Enriqueta; Cobo, Manuel (Elsevier, 2021-07) -
Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study
Viñolas, N. Nuria; Garcia‑Campelo, Rosario; Majem Tarruella, Margarita; Isla, Dolores; Gonzalez‑Larriba, José Luis; Felip Font, Enriqueta; Carcereny, Enric (BMC, 2020-11-23) -
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC
Garassino, Marina Chiara; Novello, S.; Halmos, Balazs; Felip Font, Enriqueta; Speranza, Giovanna; Gadgeel, Shirish (Elsevier, 2023-01) -
Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial
Peters, S.; Dziadziuszko, Rafal; Morabito, Alessandro; Felip Font, Enriqueta; Cheema, Parneet; Gadgeel, Shirish (Springer Nature, 2022-09) -
Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC
Andric, Zoran; Galffy, Gabriella; Szima, Barna; Stojanovic, Goran; Petrovic, Marina; Felip Font, Enriqueta; Cobo, Manuel (Elsevier, 2023-02) -
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort
Tan, Benjamin; Khattak, Adnan; Felip Font, Enriqueta; Kelly, Karen; Rich, Patricia; Wang, Ding (Springer, 2021-07) -
Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer
Shaw, Alice Tsang; Johnson, Melissa L.; Navarro Mendivil, Alejandro; Gainor, Justin F.; Thurm, Holger; Felip Font, Enriqueta; Bauer, Todd (Springer, 2020-02) -
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Felip Font, Enriqueta (American Society of Clinical Oncology, 2020-11-01) -
Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Felip Font, Enriqueta (Elsevier, 2021-12-01) -
Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study
Felip Font, Enriqueta; de Braud, Filippo G.; Maur, Michela; Loong, Herbert H.; Shaw, Alice Tsang; Vansteenkiste, Johan F. (Elsevier, 2020-03) -
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations
Felip Font, Enriqueta; Ardizzoni, Andrea; Ciuleanu, Tudor; Laktionov, Konstantin; Szilasi, Maria; Cobo, Manuel (Elsevier, 2020-03-01) -
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung
Lazar, Vladimir; Raynaud, Jacques; Magidi, Shai; Bresson, Catherine; Martini, Jean-François; Galbraith, Susan; Felip Font, Enriqueta (SAGE Publications, 2022-10-28) -
Current professional standing of young medical oncologists in Spain: a nationwide survey by the Spanish Society of Medical Oncology + MIR section
Sánchez Martínez, Domingo Antonio; Quilez‑Cutillas, Aliica; Jiménez Labaig, Pablo; Sesma, Andrea; Tarazona, Noelia; Pacheco-Barcia, V.; Felip Font, Enriqueta; Elez Fernandez, Mª Elena (Springer, 2023-03) -
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival
Lazar, Vladimir; Magidi, Shai; Girard, Nicolas; Savignoni, Alexia; Martini, Jean-François; Massimini, Giorgio; Braña Garcia, Irene; Tabernero Caturla, Josep; Felip Font, Enriqueta (Nature Research, 2021-04-28) -
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell–mediated cytotoxicity
Valencia, Karmele; Echepare, Mirari; Teijeira, Alvaro; Pasquier, Andrea; Bértolo, Cristina; Sainz Zubieta, María Cristina; Felip Font, Enriqueta (Rockefeller University Press, 2022-12-05)